Both in Diagnostics
Achieve Life Sciences vs Myriad Genetics
Over the past year ACHV returned +45.1% and MYGN returned −6.8%; their daily moves had a correlation of 0.09.
ACHV +45.1% MYGN −6.8%Growth of $1, one year, split-adjusted
| Metric | ACHV | MYGN |
|---|---|---|
| Price | $6.98 | $6.02 |
| Market cap | $719.7M | $575.8M |
| Today | +3.71% | −0.33% |
| 1 month | −0.7% | +40.7% |
| 6 months | +45.4% | +46.5% |
| Year to date | +40.4% | −2.1% |
| 1 year | +36.6% | −26.4% |
| Revenue growth (YoY) | — | −10.5% |
| Gross margin | — | 66.6% |
| Net margin | — | −22.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.7× |
| Net cash | $172.4M | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 60.5% | 85.0% |
| Short % of float | 28.1% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).